Variant Summary
- Also known as
- ARG1275GLN,RS113994087
- HGVS
- NM_004304.4:c.3824G>A,NP_004295.2:p.Arg1275Gln,NC_000002.11:g.29432664C>T,ENST00000389048.3:c.3824G>A
- Variant Type(s)
- missense_variant
- Evidence Items
- 6
Evidence Level Distribution
Level C: 2Level D: 4
Evidence Items
Showing CIViC evidence rows where gene = ALK and variant = R1275Q.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Sensitivity/Response | Neuroblastoma | Lorlatinib | 4 |
| D | Predictive | Supports | Sensitivity/Response | Neuroblastoma | Crizotinib | 3 |
| D | Predictive | Supports | Resistance | Neuroblastoma | ALK Inhibitor TAE684 | 3 |
| C | Predictive | Supports | Sensitivity/Response | Neuroblastoma | Crizotinib | 2 |
| C | Predictive | Supports | Sensitivity/Response | Neuroblastoma | Crizotinib | 2 |
| D | Predictive | Supports | Sensitivity/Response | Cancer | ALK Inhibitor TAE684 | 2 |